Articles by : Shannon Young, Associate Editor/Senior Writer

Second Sight Solutions’ Parent Company Targeted in Cyber Attack, Firm Says 340B Platforms Do Not Appear to Have Been Affected

March 27, 2025 Shannon Young, Associate Editor/Senior Writer Views

Berkeley Research Group, the parent company of Second Sight Solutions, which runs both 340B ESP and Beacon Channel Management, was targeted in an early March cyberattack.

The parent company of Second Sight Solutions, which runs both contract pharmacy claims clearinghouse vendor 340B ESP and new 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Trump-Aligned Think Tank Proposes Lowering U.S. Drug Prices Through IRA and Other Policies, Doesn’t Weigh In on 340B Program

March 27, 2025 Shannon Young, Associate Editor/Senior Writer Views

America First Policy Institute released a March 21 brief detailing how policymakers “could accelerate drug development and enhance patient health by implementing reforms that discourage other countries from freeloading off American drug innovation.”

A conservative think tank, which officials who served in President Donald Trump’s (R) first administration founded to advance his priorities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Committee Confirms Dr. Oz as CMS Administrator in Party-Line Vote, Sends Nomination to Full Chamber

March 25, 2025 Shannon Young, Associate Editor/Senior Writer Views

The Senate Finance Committee confirmed Mehmet Oz’s CMS administrator nomination on a 14-13 party-line vote.

A key Senate panel voted along party lines Tuesday afternoon to confirm Mehmet Oz as President Donald Trump’s (R) pick [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Dr. Oz’s Ties to Company that Partners With 340B Hospitals Draws Scrutiny, Senate Panel Prepares Vote on CMS Administrator Nomination

March 25, 2025 Shannon Young, Associate Editor/Senior Writer Views

Mehmet Oz, President Donald Trump’s (R) pick to lead the Centers for Medicare & Medicaid Services, drew new scrutiny this week over his ties to a health benefits company that partners with 340B hospitals.

President Donald Trump’s (R) pick of Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS) drew new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

U.S. Senate Bipartisan 340B Working Group Announces New Members, New Mexico Sends Contract Pharmacy Access Bill to Gov.

March 24, 2025 Shannon Young, Associate Editor/Senior Writer Views

U.S. Sens. Jerry Moran (R-Kan.), Shelley Moore Capito (R-W.V.) and Tammy Baldwin (D-Wis.) have announced U.S. Sens. Markwayne Mullin (R-Okla.), John Hickenlooper (D-Colo.) and Tim Kaine (D-Va.) as the newest members of the Senate 340B bipartisan working group.

The bipartisan group of six U.S. senators behind long-awaited 340B program overhaul legislation, known as the SUSTAIN 340B Act, is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Advocate Slams Federal ‘No 340B Savings for Transgender Care Act’ Proposal

March 20, 2025 Shannon Young, Associate Editor/Senior Writer Views

Peggy Tighe, a principal at Powers Law, told 340B Report that U.S. Rep. Dusty Johnson’s (R-S.D.) bill "appears to be an attempt to thwart attacks against the 340B program, perhaps to protect GOP state and federal legislators, but it is anti-states' rights and an overreaction to a false and incendiary campaign.”

A 340B program advocate this week condemned a new GOP U.S. House bill that would prohibit covered entities from using [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drugmakers Agree to Take Part in Second Round of IRA’s Medicare Drug Price Talks

March 20, 2025 Shannon Young, Associate Editor/Senior Writer Views

A dozen drugmakers have agreed to negotiate prices with the federal government as part of the second round of Medicare drug price talks under the Inflation Reduction Act.

The manufacturers behind 15 drugs selected for the second round of Medicare drug price negotiations under the Inflation Reduction Act [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Program Garners National Headlines Over Dark Money Ads, Employer Pharmacy Benefit Plans

March 18, 2025 Shannon Young, Associate Editor/Senior Writer Views

The Associated Press and Wall Street Journal recently published articles that highlighted the 340B program.

The 340B drug pricing program is drawing newfound national media attention following recent articles on a multistate dark money ad [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Confirmation Hearing for Dr. Oz, Trump’s Pick to Lead CMS, Set for Tomorrow

March 13, 2025 Shannon Young, Associate Editor/Senior Writer Views

The Senate Finance Committee announced it will hold a March 14 confirmation hearing on President Donald Trump's pick to lead CMS, Mehmet Oz.

Mehmet Oz, the celebrity heart surgeon and former U.S. Senate candidate that President Donald Trump nominated to lead the Centers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Misinformation Makes Up Small Part of 340B Conversations Online, But Garners Outsized Attention, Analysis Finds

March 11, 2025 Shannon Young, Associate Editor/Senior Writer Views

Storyful Rx analyzed more than 6,000 social media posts and articles mentioning the 340B program between Aug. 11, 2024 and Feb. 11, 2025.

Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Articles by : Shannon Young, Associate Editor/Senior Writer

Second Sight Solutions’ Parent Company Targeted in Cyber Attack, Firm Says 340B Platforms Do Not Appear to Have Been Affected

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Trump-Aligned Think Tank Proposes Lowering U.S. Drug Prices Through IRA and Other Policies, Doesn’t Weigh In on 340B Program

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Senate Committee Confirms Dr. Oz as CMS Administrator in Party-Line Vote, Sends Nomination to Full Chamber

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Dr. Oz’s Ties to Company that Partners With 340B Hospitals Draws Scrutiny, Senate Panel Prepares Vote on CMS Administrator Nomination

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

U.S. Senate Bipartisan 340B Working Group Announces New Members, New Mexico Sends Contract Pharmacy Access Bill to Gov.

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Advocate Slams Federal ‘No 340B Savings for Transgender Care Act’ Proposal

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Drugmakers Agree to Take Part in Second Round of IRA’s Medicare Drug Price Talks

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Program Garners National Headlines Over Dark Money Ads, Employer Pharmacy Benefit Plans

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Senate Confirmation Hearing for Dr. Oz, Trump’s Pick to Lead CMS, Set for Tomorrow

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Misinformation Makes Up Small Part of 340B Conversations Online, But Garners Outsized Attention, Analysis Finds

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live